Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
(Sprache: Englisch)
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics is a timely and comprehensive look at the process of nonclinical safety assessment of different types of biopharmaceuticals or biologics. Biologic drugs are a growing and...
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
133.99 €
66 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics “
Klappentext zu „Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics “
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics is a timely and comprehensive look at the process of nonclinical safety assessment of different types of biopharmaceuticals or biologics. Biologic drugs are a growing and crucial part of the overall pharmaceutical market, largely and generally because they are slightly cheaper to produce, provide higher profit margins and have a higher approval rate than conventional drugs. This reference includes the latest international guidance documents on nonclinical evaluation and a comprehensive review of vaccines, novel biopharmaceuticals, biosimilars and other biologics. By incorporating early de-risking strategies and principles of study design for each type of biopharmaceutical and comparing each to small molecule drugs, this multi-authored book is a valuable resource for all those involved in biologics development. Bibliographische Angaben
- Autor: Lisa Plitnick
- 432 Seiten, Maße: 19,2 x 24,4 cm, Gebunden, Englisch
- Herausgegeben: Lisa Plitnick, Danuta Herzyk
- Verlag: ACADEMIC PR INC
- ISBN-10: 012394810X
- ISBN-13: 9780123948106
- Erscheinungsdatum: 02.08.2013
Sprache:
Englisch
Kommentar zu "Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics"
0 Gebrauchte Artikel zu „Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics".
Kommentar verfassen